Monday, September 24, 2018 12:36:26 PM
We KNOW the FDA does not regulate medical procedures performed by qualified and licensed doctors. CaverStem has the only clinically proven procedure to treat Erectile Dysfunction with adult stem cells in the US. CaverStem ONLY use your own adult stem cells (not Embryonic stem cells) and they are not altered, manipulated or stored. Therefore FDA does not object to these procedures.
We KNOW the May AUA was successful.
We KNOW the September AUA was successful.
We KNOW several doctors in the US have been vetted and signed and are about to be opening practices (Doctors Said, Bieri, Liu, Brown, Wachs, Freedman, Narayan and Niemczyk)
We KNOW over 50 domain names have been registered showing that MANY more doctors are being vetted. These includes MANY cities and states in the USA, and now we KNOW there are domains registered in Russia (PromoMed, Dr. Pushkar), Germany, France, Switzerland (Alto Uro, Dr. Bachmann) and Austria.
We KNOW Russia will have doctors performing procedures in October 2018.
We KNOW Dr. Antonini from Italy has reached out to CMTH.
We KNOW Mells has been traveling and recruiting doctors WORLDWIDE.
We KNOW Amy Goldberg has been added to the sales team.
We KNOW Dr. Gershman has been performing the procedure with EXCELLENT results…90% success rate.
We KNOW a one-year trial has concluded and will PROVE the same results.
We KNOW the WORLDWIDE Social Media campaign has started.
We KNOW revenue has now started.
We KNOW CMTH has entered into an agreement with three institutional investors in order to wrap up existing debt and provide working capital.
We KNOW CMTH will be presenting at the Sexual Medicine Society of North America conference in Miami on November 8-11, 2018. Dr. Gershman, Dr. Liu and members of the CaverStem team will be in attendance.
We KNOW CaverStem is just ONE of EIGHT patents held by CMTH.
We KNOW Gershman and Ichim have already successfully commercialized Medistem.
We can SPECULATE that many more Doctors are currently being vetted.
We can SPECULATE that a FULL marketing campaign will start at some point, likely very soon.
We KNOW CaerStem, StemSpine & AmnioStem have all be TRADEMARKED
We KNOW CaverStem + StemSpine + AmnioStem = NASDAQ
Recent CELZ News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 08:45:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2024 08:10:25 PM
- Creative Medical Technology Holdings Initiates Development of AI-Driven Diagnostic and Treatment Program for Biologic and Chemical Exposure Utilizing its Validated iPSC Personalized Medicine Program • GlobeNewswire Inc. • 07/24/2024 01:00:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • GlobeNewswire Inc. • 07/10/2024 12:30:00 PM
- Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin • GlobeNewswire Inc. • 06/24/2024 12:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM